Syndromes and Conditions II

Price (includes one year of access and CE):  US$12 Course Code: 7SENNF-PRV-09-ddn112 CE: 2.00 Hours. Post Test Score Required for Successful Completion: 80%

Course Overview:

There are many conditions or syndromes that result in developmental disabilities. This module provides a basic overview of fragile X syndrome, pediatric HIV infection, metabolic disorders (Tay-Sachs disease and phenylketonuria), neural tube defects (anencephaly, spina bifida, hydrocephalus), and Prader-Willi syndrome. Because these syndromes and conditions have varying causes, people with these developmental disabilities may present with a wide range of physical attributes, behavioral attributes, and medical conditions. While all people with developmental disabilities should receive the same health screening and care recommended for the general population, this module highlights specific nursing and medical assessments and interventions that may be needed depending on the specific syndrome or condition.

Course Objectives:

After completion of this learning activity, the learner will be able to:

• explain the genetic basis for fragile X syndrome.
• describe the physical attributes that may be seen in males with fragile X.
• list three health challenges related to fragile X.
• define the role of the nurse in promoting effective management of health problems related to infection with HIV.
• explain the impact of the progression of HIV disease on a child's developmental process.
• describe the progression of Tay-Sachs disease.
• describe the inheritance patterns associated with Tay-Sachs disease and phenylketonuria.
• define the dietary restrictions required for the treatment of phenylketonuria.
• define the most common type of neural tube defect.
• state the most important measure specific to primary prevention of neural tube defects.
• list three health conditions associated with neural tube defects.
• describe the chromosomal disorders associated with PWS.
• describe the characteristic physical features and symptomatology associated with PWS.
• define the components of effective treatment for persons with PWS.

This courseware was made possible in part by grant number R43 NR04738-03 from the National Institute of Nursing Research (NINR). Its contents are solely the responsibility of the authors.

Copyright© 2007 by HealthSoft, Inc. All Rights Reserved.

HealthSoft, Inc. is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

It has been assigned code 7SENNF-PRV-09.

This course is updated annually. Expiration date: 5/1/11

The faculty and planners of this course have no vested interests to disclose.

This course has received no commercial support.